Antibiotice Iasi Calls Shareholders To Approve Contracting RON35M Credit Facility From Banca Transilvania

01.25.2024 By Ecaterina Craciun

The Board of Directors of pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) announced in a stock market report on Thursday (Jan. 25, 2024) that it has called shareholders for a meeting on February 29, 2024 to vote on contracting a RON35 million credit facility for the company's current activity.

To read the full story, please login. Not a member? Subscribe here.

Reveal Romania! Business news & views.
Find out all you need by reading the entire story
To invest in Romania, you need to find out about its opportunities.
To close a strategic partnership with a Romanian company, you need to learn about its market position and whether it is a trustworthy partner
To grow here, you need to be informed

Subscribe now
Only 50 euros/month (VAT not included)
Get access to reports, news and statistics in the main sectors of Romania’s economy. Follow the strategic moves of companies operating in Romania. We will keep you updated on the latest business events.
Contact: E: newsroom@zfenglish.com (newsroom), marketing@zfenglish.com (Marketing & PR), sales@zfenglish.com (subscriptions)
T: 0040-318.256.431 (Newsroom)
0040-318.256.158, 0040-318.256.408 (Subscriptions Department)
0040-318.256.469, 0040-318.256.470 (Advertising Sales Department)
0040-318.256.427, 0040-318.256.129 (Marketing & PR)

LOGIN / Lost password?

Keywords:: Antibiotice Iasi; , credit facility

Comment

Username:
Password: